You are here

Home › Listings › Technology › Diagnamed Holdings Corp.

Diagnamed Holdings Corp.

Diagnamed Holdings Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Technology
Symbol: 
DMED
CSE Index: 
Currency: 

DiagnaMed Holdings Corp. delivers innovative technology solutions for the cleantech and life sciences industries, with a focus on hydrogen production and AI-driven drug discovery and diagnostics.

You are here

Home

Diagnamed Holdings Corp. (DMED)

SEDAR Information

Search form

Company Info

Address
550 Burrard Street - #2900
Vancouver, BC V6C 0A3
Canada
Phone
1-855-439-2276
Email
Info@diagnamed.com
Website
https://www.diagnamed.com
Listing date
Tuesday, November 8, 2022
Transfer Agent
Marrelli Trust Company Limited

Capitalization

Issued & Outstanding: 
81408640
Reserved for Issuance: 
6250000

Company Officers

Fabio Chianelli , President, Chief Executive Officer
Jing Peng, Chief Financial Officer and Corporate Secretary

News Releases

03/03/2025

DiagnaMed Granted FDA Orphan Drug Designation for Molecular Hydrogen to Treat Amyotrophic Lateral Sclerosis

27/02/2025

DiagnaMed Announces LIFE Offering of up to $510,000

Bulletins

07/11/2022

2022-1109 - New Listing - Diagnamed Holdings Corp. (DMED)

Le 7 novembre/November 2022

The common shares of Diagnamed Holdings Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

CSE Filings

Form 9 - Notice of Proposed Issuance of Listed Securities

Form 7 - Monthly Progress Report

Form 5 - Quarterly Listing Statement December 31, 2024

Form 7 - Monthly Progress Report

Form 5A: Annual Listing Summary - September 30, 2024